Psoriasis is a skin condition with symptoms that often include red patches of skin covered by scales. These patches are called "psoriatic plaques." While there are many different types of psoriasis, about 80% of people with some form of psoriasis have plaque psoriasis.
REMICADE® is approved for the treatment of adult patients with chronic severe (extensive and/or disabling) plaque psoriasis under the care of a physician who will determine if REMICADE® is appropriate considering other available therapies. With REMICADE®, some patients begin to see improvement in symptoms such as plaque thickness, redness, and flakiness in as few as 2 weeks. Individual results may vary. It's also the only medication of its kind to require as few as 6 treatments a year after 3 starter doses. That's once every 8 weeks. To learn more, visit About REMICADE® and ask your doctor if REMICADE® is right for you.